The Role of SAMe in the Treatment of Liver Disease Roger WilliamsCharles S. Lieber Introduction 18 October 2012 Pages: 1 - 2
Aetiology and Pathophysiology of Chronic Liver Disorders J. SchölmerichA. Holstege OriginalPaper 18 October 2012 Pages: 3 - 22
Interaction of Alcohol with Other Drugs and Nutrients C. S. Lieber OriginalPaper 18 October 2012 Pages: 23 - 44
Traditional Management of Liver Disorders M. MessnerP. Brissot OriginalPaper 18 October 2012 Pages: 45 - 57
Mechanisms and Consequences of the Impaired Trans-Sulphuration Pathway in Liver Disease: Part I José M. MatoFernando CorralesCarmen Cabrero OriginalPaper 18 October 2012 Pages: 58 - 64
Mechanisms and Consequences of the Impaired Trans-Sulphuration Pathway in Liver Disease: Part II E. PisiG. Marchesini OriginalPaper 18 October 2012 Pages: 65 - 72
Extrahepatic Cell Membrane Lipid Abnormalities and Cellular Dysfunction in Liver Disease James S. Owen OriginalPaper 18 October 2012 Pages: 73 - 83
Cellular Mechanisms of Intrahepatic Cholestasis Peter J. Meier-Abt OriginalPaper 18 October 2012 Pages: 84 - 97
Biochemistry and Pharmacology of S-Adenosyl-L-Methionine and Rationale for its Use in Liver Disease Rajender K. ChawlaHerbert L. BonkovskyJohn T. Galambos OriginalPaper 18 October 2012 Pages: 98 - 110
Role of S-Adenosyl-L-Methionine in the Treatment of Intrahepatic Cholestasis P. AlmasioM. BortoliniM. Coltorti OriginalPaper 18 October 2012 Pages: 111 - 123
Metabolism of Exogenous S-Adenosyl-L-Methionine in Patients with Liver Disease G. L. KayeJ. C. BlakeA. K. Burroughs OriginalPaper 18 October 2012 Pages: 124 - 128